The Community Guide

- gsearch

Search Results

Narrow Results:

2019 1
2015 1
2012 1

The BAN study team 1

Journal Article 3

1 - 3 of 3 Results

Refine Results

Refine Results:

Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial

CITE Title : Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial Personal Author(s) : Jamieson, Denise J;Chasela, Charles S;Hudgens, Michael G;King, Caroline C;Kourtis, Athena P;Kayira, Dumbani;Hosseinipour, Mina C;Kamwendo, Deborah D;Ellington, Sascha R;Wiener, Jeffrey B;Fiscus, Susan A;Tegha, Gerald;Mofolo, Innocent A;Sichali, Dorothy S;Adair, Linda S;Knight, Rodney J;Martinson, Francis;Kacheche, Zebrone;Soko, Alice;Hoffman, Irving;van der Horst, Charles; Corporate Authors(s) : The BAN study team Published Date : April 26 2012 Source : Lancet. 379(9835):2449-2458 URL : https://stacks.cdc.gov/view/cdc/33567 Jamieson, Denise J et al. (2012). Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. 379(9835). Jamieson, Denise J et al. "Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial" 379, no. 9835 (2012) Jamieson, Denise J et al. "Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial" vol. 379, no. 9835, 2012 Export RIS Citation Information.

:

Jamieson, Denise J ;

Chasela, Charles S

April 26 2012 | Lancet. 379(9835):2449-2458

:

BackgroundIn resource-limited settings where no safe alternative to breastfeeding exists, WHO recommends that antiretroviral prophylaxis be given to e...
Antiretroviral treatment is associated with iron deficiency in HIV-infected Malawian women that is mitigated with supplementation, but is not associated with infant iron deficiency during 24 weeks of exclusive breastfeeding

CITE Title : Antiretroviral treatment is associated with iron deficiency in HIV-infected Malawian women that is mitigated with supplementation, but is not associated with infant iron deficiency during 24 weeks of exclusive breastfeeding Personal Author(s) : Widen, Elizabeth M;Bentley, Margaret E;Chasela, Charles S;Kayira, Dumbani;Flax, Valerie L;Kourtis, Athena P;Ellington, Sascha R;Kacheche, Zebrone;Tegha, Gerald;Jamieson, Denise J;van der Horst, Charles M;Allen, Lindsay H;Shahab-Ferdows, Setareh;Adair, Linda S; Published Date : 7 1 2015;7-1-; Source : J Acquir Immune Defic Syndr. 69(3):319-328 URL : https://stacks.cdc.gov/view/cdc/34411 Widen, Elizabeth M et al. (2015). Antiretroviral treatment is associated with iron deficiency in HIV-infected Malawian women that is mitigated with supplementation, but is not associated with infant iron deficiency during 24 weeks of exclusive breastfeeding. 69(3). Widen, Elizabeth M et al. "Antiretroviral treatment is associated with iron deficiency in HIV-infected Malawian women that is mitigated with supplementation, but is not associated with infant iron deficiency during 24 weeks of exclusive breastfeeding" 69, no. 3 (2015) Widen, Elizabeth M et al. "Antiretroviral treatment is associated with iron deficiency in HIV-infected Malawian women that is mitigated with supplementation, but is not associated with infant iron deficiency during 24 weeks of exclusive breastfeeding" vol. 69, no. 3, 2015 Export RIS Citation Information.

:

Widen, Elizabeth M ;

Bentley, Margaret E

7 1 2015 | J Acquir Immune Defic Syndr. 69(3):319-328

:

ObjectiveIn resource-limited settings without safe alternatives to breastfeeding, the WHO recommends exclusive breastfeeding and antiretroviral (ARV) ...
Antiretroviral drug concentrations in breastmilk, maternal HIV viral load, and HIV transmission to the infant: results from the BAN study

CITE Title : Antiretroviral drug concentrations in breastmilk, maternal HIV viral load, and HIV transmission to the infant: results from the BAN study Personal Author(s) : Davis, Nicole L;Corbett, Amanda;Kaullen, Josh;Nelson, Julie A. E.;Chasela, Charles S;Sichali, Dorothy;Hudgens, Michael G;Miller, William C;Jamieson, Denise J;Kourtis, Athena P; Published Date : 4 01 2019 Source : J Acquir Immune Defic Syndr. 80(4):467-473 URL : https://stacks.cdc.gov/view/cdc/76186 Davis, Nicole L et al. (2019). Antiretroviral drug concentrations in breastmilk, maternal HIV viral load, and HIV transmission to the infant: results from the BAN study. 80(4). Davis, Nicole L et al. "Antiretroviral drug concentrations in breastmilk, maternal HIV viral load, and HIV transmission to the infant: results from the BAN study" 80, no. 4 (2019) Davis, Nicole L et al. "Antiretroviral drug concentrations in breastmilk, maternal HIV viral load, and HIV transmission to the infant: results from the BAN study" vol. 80, no. 4, 2019 Export RIS Citation Information.

:

Davis, Nicole L ;

Corbett, Amanda

4 01 2019 | J Acquir Immune Defic Syndr. 80(4):467-473

:

Background:Concentration of antiretroviral (ARV) drug found in plasma, and amounts of drug excreted into breastmilk, may affect HIV viral load and pot...